These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6445277)

  • 21. Binding of [3H]gamma-vinyl-GABA to GABA-transaminase in brain homogenates.
    Gale K
    Life Sci; 1984 Feb; 34(7):701-6. PubMed ID: 6700374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex.
    Otero Losada ME; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):169-72. PubMed ID: 3010141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.
    Stoof JC; Mulder AH
    Eur J Pharmacol; 1977 Nov; 46(2):177-80. PubMed ID: 590329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
    Hill JM
    Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
    Andersson U; Häggström JE
    Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems.
    Palfreyman MG; Huot S; Lippert B; Schechter PJ
    Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABA agonist treatment improves tardive dyskinesia.
    Tamminga CA; Thaker GK; Ferraro TN; Hare TA
    Lancet; 1983 Jul; 2(8341):97-8. PubMed ID: 6134975
    [No Abstract]   [Full Text] [Related]  

  • 29. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    Biochem Pharmacol; 1980 Jun; 29(11):1451-4. PubMed ID: 7396979
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro and in vivo effects on brain GABA metabolism of (S)-4-amino-5-fluoropentanoic acid, a mechanism-based inactivator of gamma-aminobutyric acid transaminase.
    Silverman RB; Muztar AJ; Levy MA; Hirsch JD
    Life Sci; 1983 Jun; 32(24):2717-23. PubMed ID: 6855467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology of GABA-transaminase inhibitors.
    Palfreyman MG; Schechter PJ; Buckett WR; Tell GP; Koch-Weser J
    Biochem Pharmacol; 1981 Apr; 30(8):817-24. PubMed ID: 6113832
    [No Abstract]   [Full Text] [Related]  

  • 32. The differential effects of GABA-transaminase inactivation in the chick retina and brain.
    Rando RR; Coburn J; Parkinson D
    J Neurochem; 1982 Oct; 39(4):1147-51. PubMed ID: 7119785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Picrotoxin convulsions and GABA metabolism after injection of anticonvulsants in chicks.
    Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Eur J Pharmacol; 1976 Nov; 40(1):101-6. PubMed ID: 991920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the enantiomers of 5-hexyne-1,4-diamine on ODC, GAD and GABA-T activities in the rat.
    Danzin C; Casara P; Claverie N; Grove J
    Biochem Pharmacol; 1983 Mar; 32(5):941-2. PubMed ID: 6838643
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gamma-aminobutyric acid system in the cat brain during convulsions].
    Snisar' IA; Orekhov VS; Sytinskiĭ IA
    Vopr Med Khim; 1982; 28(5):60-3. PubMed ID: 7179835
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathophysiology of tardive dyskinesia.
    Gunne LM; Häggström JE
    Psychopharmacology Suppl; 1985; 2():191-3. PubMed ID: 3858799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide on GABA, glutamic acid, activities of GABA-T and GAD in rat brain cerebral cortex.
    Jayakumar AR; Sujatha R; Paul V; Asokan C; Govindasamy S; Jayakumar R
    Brain Res; 1999 Aug; 837(1-2):229-35. PubMed ID: 10434007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of isolation-induced aggressive behavior with GABA transaminase inhibitors.
    DaVanzo JP; Sydow M
    Psychopharmacology (Berl); 1979 Mar; 62(1):23-7. PubMed ID: 108744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The histochemical localization of GABA-transaminase in the efferents of the striatum.
    Vincent SR; Kimura H; McGeer EG
    Brain Res; 1981 Oct; 222(1):198-203. PubMed ID: 7296268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.